Next report date
Report period
Q2 2024
EPS estimate
−0.21SEK
Revenue estimate
900.00 KSEK
−89.32 MSEK
7.63 MSEK
111.49 M
About MEDIVIR AB
Sector
CEO
Jens Lindberg
Headquarters
Huddinge
Website
Employees (FY)
10
Founded
1987
ISIN
SE0020181014
FIGI
BBG000HPVJQ1
Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects, and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MVIR is 3.21 SEK — it has increased by 1.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MEDIVIR AB stocks are traded under the ticker MVIR.
MEDIVIR AB is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
MVIR stock is 7.62% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is MEDIVIR AB there?
MVIR earnings for the last quarter are −0.28 SEK per share, whereas the estimation was −0.37 SEK resulting in a 23.53% surprise. The estimated earnings for the next quarter are −0.24 SEK per share. See more details about MEDIVIR AB earnings.
MEDIVIR AB revenue for the last quarter amounts to 4.40 M SEK despite the estimated figure of 800.00 K SEK. In the next quarter revenue is expected to reach 1.90 M SEK.
Yes, you can track MEDIVIR AB financials in yearly and quarterly reports right on TradingView.
MVIR stock has risen by 9.56% compared to the previous week, the month change is a 16.73% rise, over the last year MEDIVIR AB has showed a 49.51% decrease.
Today MEDIVIR AB has the market capitalization of 352.93 M, it has increased by 7.14% over the last week.
No, MVIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MVIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIVIR AB stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 10.00 employees. See our rating of the largest employees — is MEDIVIR AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIVIR AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIVIR AB stock shows the sell signal. See more of MEDIVIR AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDIVIR AB future price: according to them, MVIR price has a max estimate of 54.00 SEK and a min estimate of 10.45 SEK. Read a more detailed MEDIVIR AB forecast: see what analysts think of MEDIVIR AB and suggest that you do with its stocks.